RAPers please comment, page-76

Your last sentence is very key....

Consolidation or not doesn't matter it's the market cap of the company which is key

Analyse the market cap using the initial announcement fully diluted 900M shares assuming a "scenario" of 1.3c float , which won't be happening at that low a price , so worst case at 10c its a $90M cap well under RAP currently , and only 1/5th of the current MNQ share price

Now think if RAP gets FDA approval what that will do to its share price and hence MNQ impact as well you can see the growth value in MNQ cap from current levels

This is what the astute investor is seeing at the moment in the stock , in 6 months this can be performing around the 10-15c levels